Pharmaceutical Business review

ScripsAmerica signs new distribution deal with generic pharmaceutical company

The approval as the distributor follows ScripsAmerica’s completion of a screening process requiring multiple business references and the ability to provide quality of pharmaceutical distribution services.

ScripsAmerica CEO Bob Schneiderman said, "We believe this will enable ScripsAmerica to expand its customer base by not only increasing the number of pharmaceutical products that we offer on the whole, but also offering the top quality products from the world’s largest manufacturer of generic drugs that are in high demand."

The company expects that the completion of a screening process will have a positive impact on its acquisition of new distribution contracts.